Previous 10 | Next 10 |
Increased Convenience for Patient Candidates; Increased Productivity and Reduced Costs for Company Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fr...
Myomo, Inc. (MYO) Q1 2020 Results Conference Call May 14, 2020 04:30 PM ET Company Participants Kim Golodetz - Investor Relations-LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Scott Henry - ROTH Capital Greg B...
Myomo (NYSEMKT: MYO ): Q1 GAAP EPS of -$2.51 misses by $0.45 . More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
21% Year-Over-Year Revenue Growth; 51% Sequential Increase in Authorization Backlog Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers inc...
Management to host Financial Results Conference Call at 4:30 p.m. ET Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and up...
Gainers: Medigus (NASDAQ: MDGS ) +44% . More news on: Medigus Ltd., Indonesia Energy Corporation Limited, National Holdings Corporation, Stocks on the move, , Read more ...
Medigus (NASDAQ: MDGS ) +76% on first order for COVID-19 blood test . More news on: Medigus Ltd., Myomo, Inc., Akari Therapeutics, Plc, Stocks on the move, , Read more ...
Ellington Financial EFC +54% as book value holds up . More news on: Myomo, Inc., AG Mortgage Investment Trust, Inc., Anworth Mortgage Asset Corporation, Stocks on the move, , Read more ...
Myomo (NYSEMKT: MYO ) jumps 24% premarket on average volume in reaction to its announcement that more than 700 people are waiting for insurance reimbursement for its MyPro powered arm brace, up from 594 at the end of 2019. Backlog of authorized units has increased to 80 from 53...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported its pipeline of MyoPro candidates continu...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...